Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
Vahdat LT, Papadopoulos K, Balmaceda C, McGovern T, Dunleavy J, Kaufman E, Fung B, Garrett T, Savage D, Tiersten A, Ayello J, Bagiella E, Heitjan D, Antman K, Hesdorffer C. Vahdat LT, et al. Among authors: hesdorffer c. Clin Cancer Res. 1998 Jul;4(7):1689-95. Clin Cancer Res. 1998. PMID: 9676843 Clinical Trial.
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP, Ayello J, Tugulea S, Heitjan DF, Williams C, Reiss RF, Vahdat LT, Suciu-Foca N, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: hesdorffer cs. J Hematother. 1997 Feb;6(1):61-8. doi: 10.1089/scd.1.1997.6.61. J Hematother. 1997. PMID: 9112219 Clinical Trial.
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Papadopoulos KP, Garvin JH, Fetell M, Vahdat LT, Garrett TJ, Savage DG, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: hesdorffer cs. Bone Marrow Transplant. 1998 Oct;22(7):661-7. doi: 10.1038/sj.bmt.1701408. Bone Marrow Transplant. 1998. PMID: 9818693
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: hesdorffer cs. J Neurooncol. 1999 Sep;44(2):155-62. doi: 10.1023/a:1006391619009. J Neurooncol. 1999. PMID: 10619499 Clinical Trial.
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
Papadopoulos KP, Ayello J, Reiss RF, Troxel A, Kaufman E, Vahdat LT, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: hesdorffer cs. J Hematother Stem Cell Res. 1999 Aug;8(4):357-63. doi: 10.1089/152581699320117. J Hematother Stem Cell Res. 1999. PMID: 10634173 Clinical Trial.
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer.
Papadopoulos KP, Egorin MJ, Huang M, Troxel AB, Kaufman E, Balmaceda CM, Vahdat LT, Hesdorffer CS. Papadopoulos KP, et al. Among authors: hesdorffer cs. Cancer Chemother Pharmacol. 2001;47(1):45-50. doi: 10.1007/s002800000193. Cancer Chemother Pharmacol. 2001. PMID: 11221961 Clinical Trial.
Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
Vahdat L, Papadopoulos K, Lange D, Leuin S, Kaufman E, Donovan D, Frederick D, Bagiella E, Tiersten A, Nichols G, Garrett T, Savage D, Antman K, Hesdorffer CS, Balmaceda C. Vahdat L, et al. Among authors: hesdorffer cs. Clin Cancer Res. 2001 May;7(5):1192-7. Clin Cancer Res. 2001. PMID: 11350883 Clinical Trial.
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
Vahdat LT, Balmaceda C, Papadopoulos K, Frederick D, Donovan D, Sharpe E, Kaufman E, Savage D, Tiersten A, Nichols G, Haythe J, Troxel A, Antman K, Hesdorffer CS. Vahdat LT, et al. Among authors: hesdorffer cs. Bone Marrow Transplant. 2002 Aug;30(3):149-55. doi: 10.1038/sj.bmt.1703592. Bone Marrow Transplant. 2002. PMID: 12189532 Clinical Trial.
98 results